Skip Navigation

Reports of Patent, Design and Trade Mark Cases 2006 123(25):872-878; doi:10.1093/rpc/2006rpc34
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Add to My Personal Archive
Right arrowRequest Permissions
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Crown Copyright

[2006] R.P.C. 34

RE MASSACHUSETTS INSTITUTE OF TECHNOLOGY

Court of Justice of the European Communities (Second Chamber)1

Case C-431/04 (CWA Timmermans (President), R Schintgen, R Silva de Lapuerta, G Arestis (Rapporteur) and J Klucka, Judges): May 4, 20062

[2006] R.P.C. 34

Supplementary protection certificate—Medicinal products—Meaning of "combination of active ingredients'—Whether excipient which allowed slow-release form of drug an "active ingredient".

Key Words: EC law • European patents • Germany • Ingredients • Pharmaceuticals • Supplementary protection certificates

1 Language of the case: German. The source of this judgment is the website of the Court of Justice of the European Communities and is subject to a disclaimer and copyright notice. The electronic version from which this report has been taken is not authentic and is subject to amendment.

2 Paragraph numbers in this judgment are as assigned by the court.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.